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The human gut harbors a dynamic and complex microbial ecosystem, consisting of approximately 1 kg of
bacteria in the average adult, approximately the weight of the human brain. The evolutionary formation
of a complex gut microbiota in mammals has played an important role in enabling brain development
and perhaps sophisticated social interaction. Genes within the human gut microbiota, termed the
microbiome, signiﬁcantly outnumber human genes in the body, and are capable of producing a myriad of
neuroactive compounds. Gut microbes are part of the unconscious system regulating behavior. Recent
investigations indicate that these microbes majorly impact on cognitive function and fundamental
behavior patterns, such as social interaction and stress management. In the absence of microbes,
underlying neurochemistry is profoundly altered. Studies of gut microbes may play an important role in
advancing understanding of disorders of cognitive functioning and social interaction, such as autism.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Humans live in a symbiotic relationship with gut microbes: we
provide them with a constant source of nutrition, while in return
they help us in a variety of ways including enabling optimal brain
development and subsequent functioning (Geurts et al. 2013; Chen
et al., 2013). Many human genes are homologs of bacterial genes,
mainly derived by descent, but some by gene transfer from bacteria
(McFall-Ngai et al., 2013). The word commensal is derived from the
Latin term “cum mensa”, which means “eating together”. It has
been postulated that in the absence of bacteria humans would not
have developed the current level of cognitive performance
(Montiel-Castro et al., 2013) We are fundamentally dependent on a
myriad of essential neurochemicals produced by microbes. For
example, the brain's serotonergic system, which plays a key role in
emotional activity, does not develop appropriately in the absence of
microbes (Clarke et al., 2013). Gut microbes are part of the
unconscious system regulating behavior. Of major importance for
societal functioning is the human trait of sociability. We are social
creatures with superior cognitive functioning, which enabled us to
become the dominant species on the planet. In rodents, who are
raised without any bacteria, one sees altered sociability with clear
autistic-like patterns of behavior (Desbonnet et al., 2014). Withiny, Cork University Hospital,
Ltd. This is an open access article uan evolutionary framework colonization with crowds of bacteria
facilitated mammalian group living in social crowds (Lombardo,
2008; Troyer, 1984), and thus the capacity for environmental
dominance. Here we will review the evidence in support of these
assertions and the potential role of gut microbes in psychiatry.
Unlike many recent reviews published in specialist journals, the
current review is aimed at practicing psychiatrists.1. Brainegutemicrobiota axis
The general scaffolding of the brainegutemicrobiota axis (BGM)
includes the central nervous system (CNS), the neuroendocrine and
neuroimmune systems, the sympathetic and parasympathetic arms
of the autonomic nervous system (ANS), the enteric nervous system
(ENS) and most importantly the intestinal microbiota (Mayer,
2011). These components interact to form a complex reﬂex
network with afferent ﬁbers that project to integrative CNS
structures and efferent projections to the smoothmuscle (Grenham
et al., 2011). Through this bidirectional communication network,
signals from the brain can inﬂuence the motor, sensory and
secretory modalities of the gut and conversely, visceral messages
from the gut can inﬂuence brain function (Grenham et al., 2011;
Montiel-Castro et al., 2013). Less extensively studied, but increas-
ingly appreciated, is the potential impact of the enteric microbiota
on brain function (Khanna and Tosh, 2014). The gut microbiotander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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protozoa, fungi and viruses, all of which have co-evolved with the
human host. These microorganisms perform vital functions, which
are essential for host health, including food processing, digestion of
complex indigestible polysaccharides, synthesis of vitamins, and
inhibition of pathogens (Cecchini et al., 2013; Ramakrishna, 2013).
2. Key communication routes
The bidirectional communication between gut microbes and the
brain occurs via a number of routes (Fig. 1) (Dinan and Cryan, 2013).
The vagus nerve (cranial nerve X) has both efferent and afferent
divisions, and plays a fundamental role in enabling signals from
brain to gut and vice versa. Activation of the vagus nerve has also
been shown to have a marked anti-inﬂammatory capacity,Fig. 1. The multiple bidirectional routes of communication between the brain and the gut mi
(HPA), cytokines produced by the immune system, tryptophan metabolism and productionprotecting against microbial-induced sepsis, an impact mediated
by the acetylcholine nicotinic receptor a7 subunit (Boeckxstaens,
2013). Many of the effects of the gut microbiota or potential
probiotics (live bacteria with a health beneﬁt) on brain function are
dependent on vagal activation (Bercik et al., 2012). However, vagus-
independent mechanisms are also at play in microbiotaebrain
interactions, as vagotomy fails to inﬂuence certain aspects of
communication.
The immune system provides a further route of communication
between gut microbes and the brain. Microbiota and probiotic
agents have direct effects on the immune system. Indeed, the
innate and adaptive arms collaborate to maintain homeostasis at
the luminal surface of the intestinal hostemicrobial interface,
which is crucial for maintaining health. The immune system also
exerts a bidirectional communication with the CNS, making it acrobiota. These routes include the vagus nerve, the hypothalamic-pituitary-adrenal axis
of short chain fatty acids.
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(Hueston and Deak, 2014). In addition, indirect effects of the gut
microbiota and probiotics on the innate immune system can result
in alterations in the circulating levels of pro- and anti-inﬂammatory
cytokines that directly affect brain function, especially areas such as
the hypothalamus, where interleukin (IL)-1 and IL-6 provide a
potent release of corticotrophin releasing hormone (CRH)
(Viswanathan et al., 2013). CRH is the dominant peptide regulator
of the hypothalamic-pituitary-adrenal axis (HPA), which itself
provides another bidirectional route of communication.
Tryptophan is an essential amino acid and is a precursor tomany
biologically active agents, including the neurotransmitter serotonin
(5HT): most of the peripheral tryptophan is metabolized to
kynurenine. The initial rate-limiting step in the kynurenine meta-
bolic cascade is catalyzed by either indoleaminee2,3edioxygenase
or the largely hepatic-based tryptophan 2,3edioxygenase (Clarke
et al., 2012b). The activity of both enzymes can be induced by
inﬂammatory mediators and by corticosteroids (Sainio, 1997; Zhou
et al., 2012). There is some evidence to suggest that a probiotic
bacterium, Biﬁdobacterium infantis, can alter concentrations of
kynurenine (Clarke et al., 2012a).
Gut bacteria contribute to host metabolism, for example by
production of metabolites such as bile acids, choline and short-
chain fatty acids (SCFAs) that are essential for host health. Indeed,
complex carbohydrates such as dietary ﬁber can be digested and
subsequently fermented in the colon by gut microorganisms into
SCFAs such as nebutyrate, acetate and propionate, which are
known to have neuroactive properties (Russell et al., 2013).
Certainly, these SCFAs can enter the blood and act in brain regions
through two discrete 7-transmembrane G protein coupled re-
ceptors (Tan et al., 2014), free fatty acid receptor 2 (FFA2) and FFA3.
Bacteria also have the capacity to generate many neurotrans-
mitters and neuromodulators. For example, certain Lactobacillus
and Biﬁdobacterium species produce gamma-aminobutyric acid
(GABA); Escherichia, Bacillus and Saccharomyces spp. produce
norepinephrine (NE); Candida, Streptococcus, Escherichia and
Enterococcus spp. produce 5HT; Bacillus produces dopamine (DA);
and Lactobacillus produces acetylcholine (Lyte, 2011, 2013; Wikoff
et al., 2009). Some probiotics can modulate the concentrations of
opioid and cannabinoid receptors in the gut epithelium (Rousseaux
et al., 2007). However, how this local effect occurs or translates to
the anti-nociceptive effects seen in animalmodels of visceral pain is
currently unclear. It is conceivable that secreted neurotransmitters
of microorganisms in the intestinal lumen may induce epithelial
cells to release molecules that in turn modulate neural signaling
within the ENS, or act directly on primary afferent axons (Mcvey
Neufeld et al., 2013).
The outer extracellular polysaccharide coating of probiotic
bacteria is largely responsible for many of their health-promoting
effects (Claes et al., 2010). Indeed, the extracellular poly-
saccharide of the probiotic Biﬁdobacterium breve UCC2003 protects
the bacteria from acid and bile in the gut and shields the bacteria
from the host immune response. Indeed, as with neuroactive me-
tabolites, cell wall components of microorganisms in the intestinal
lumen or attached to epithelial cells are poised to induce epithelial
cells to release molecules that in turn modulate neural signaling or
that act directly on primary afferent axons.
3. Colonization of the gut
There are approximately 150e200 common and approximately
1000 less frequent bacterial species in the gut. The genes encoded
by the human gut microbiota, collectively referred to as the
microbiome, are over 100-fold more abundant than the genes of
the human genome (Hamady and Knight, 2009). The colon harborsthe greatest numbers of microorganisms in the human gut, with
the vast majority of these indigenous microbes being strict anaer-
obes (Eckburg et al., 2005). The total weight of microbes in the adult
human intestine is approximately the same weight as the human
brain.
The composition and function of the intestinal microbiota has
been the subject of intense scrutiny (Box 1), ﬁrst using culture-
dependant microbiological techniques (Grenham et al., 2011) and
more recently, using culture-independent 16S rRNA gene
sequence-based techniques, which allow greater insight into the
microbial composition and diversity of this complex (Armougom
and Raoult, 2008; Qin et al., 2010). While advances in meta-
genomic technologies have revealed the composition of the human
gut microbiota from early infancy (Palmer et al., 2007) through to
elderly (Claesson et al., 2012), far less is known about the physio-
logical impact this microbiota has on host health, including that of
the brain. Indeed, understanding the inﬂuence of the gut micro-
biota on host health has been described as one of the most exciting
areas in all medicine (Shanahan, 2012).
At birth the human brain is highly under-developed and the gut
is generally regarded as entirely sterile. However, it is worth noting
that there is an increasing body of evidence challenging the sterile-
womb paradigm (Funkhouser and Bordenstein, 2013) and that
transmission of certain microbes already occurs in utero. None-
theless, passage through the birth canal exposes the baby to the
mother's microbiota. Initial colonization is dictated by the mother's
microbes and the hospital environment. This colonization plays a
fundamental role in brain development in the early post-natal
weeks. The subsequent microbial composition of the neonatal gut
is inﬂuenced by a number of factors including antibiotic use, diet,
mode of delivery, environmental factors, and the maternal micro-
biota (Koenig et al., 2011; Marques et al., 2010; Dominguez-Bello
et al., 2010). For example, the microbiota of formula-fed infants
has been reported to be more diverse than breastfed infants,
containing higher proportions of Bacteroides, Clostridium, and
Enterobacteriaceae. Furthermore, vaginally delivered infants are
colonized by the fecal and vaginal bacteria of the mother, whereas
infants delivered by caesarean section (CS) are colonized by other
bacteria from environmental sources including health-care
workers, air, medical equipment and other newborns (Faa et al.,
2013). Efforts to replicate the intestinal microbiota of breastfed
infants via formula-feeding have led to the incorporation of
prebiotics (food ingredients that selectively stimulate the growth
and/or activity of one or more bacterial species in the colon and
thereby beneﬁcially affect the host) in infant formulae. It has been
reported that a combination of galacto-oligosaccharides (GOS) and
fructo-oligosaccharides (FOS), at ratios similar to the oligosaccha-
ride composition of human breast milk, can stimulate the growth of
biﬁdobacteria and inﬂuence species distribution in the gut micro-
biota, and SCFA production levels to mimic those of breastfed
infants (Park et al., 2013). Recent rodent studies have also shown
that prebiotic supplementation with FOS and GOS can increase the
expression of neurotransmitters and neuromodulators in the
hippocampus, a key brain area involved in learning and memory
(Savignac et al., 2013; De Vadder et al., 2014).
4. Gut microbiota components
The intestinal microbiota of newborn infants is characterized by
low diversity and a relative dominance of the phyla Proteobacteria
and Actinobacteria in the early period following birth. As time after
birth increases, the microbiota becomes more diverse with the
emergence and dominance of Firmicutes and Bacteroidetes. Full-
term, vaginally delivered, breastfed, non-antibiotic treated infants
are optimal for the development of the neonatal microbiota (Alex
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obacteria, staphylococci and streptococci are the earliest to colo-
nize, taking advantage of the redox potential and available oxygen
of the newborn gut. These earliest colonizers consume the oxygen
in the gut, thereby creating an anaerobic environmentwhich allows
the proliferation of the strict anaerobes, Clostridium, Bacteroides
and biﬁdobacteria, with biﬁdobacteria becoming dominant and
outnumbering all other bacterial groups and species within the ﬁrst
weeks of life. The neonatal microbiota is highly dynamic and is
characterized by instability and low diversity. By the end of the ﬁrst
year of life, infants possess a microbial proﬁle distinct for each
infant, converging towards the characteristic microbiota of an adult
and by 2.5 years of age the microbiota fully resembles that of an
adult in terms of composition (Lobo et al., 2014).
The adult microbiota has been reported to be relatively stable
over time in addition to being more complex than that of the
neonate (Hamady and Knight, 2009). There are large interpersonal
differences in the microbiota of healthy adults, even between
identical twins. However, a shared core gut microbiome exists,
exerting a common functionality within the host. The gut micro-
biota of adults is dominated primarily by members of the Bacter-
oidetes and Firmicutes phyla and more recently the adult
microbiome was classiﬁed into three different ‘enterotypes’. These
‘enterotypes’ are dominated by Prevotella, Ruminococcus and
Bacteroides, respectively, and appear to be independent of sex, age,
nationality and body mass index (BMI) (Arumugam et al., 2011).
5. Microbes and neurotransmission
Which of the 4e5million non-redundant bacterial genes, which
have been sequenced from the human gut, are fundamental for
brain development? At this point we do not know. It is tempting to
speculate that those microbes, which produce and secrete neuro-
modulators or their precursors, have an especially important role to
play in neurodevelopment. GABA, which is the main inhibitory
neurotransmitter in the human brain, is produced by many lacto-
bacilli, and for most babies born per vaginum are the ﬁrst bacteria to
which they are exposed. As mentioned above other essential neu-
rotransmitters such as 5HT, NE, DA are also produced by microbes.
There are a variety of techniques used for studying the impact of
the gut microbiota on the brain: these techniques include germ-
free (GF) studies in mice, antibiotic and probiotic studies, infec-
tion studies and fecal transplantation (Cryan and Dinan, 2012;
Foster and McVey Neufeld, 2013). Matsumoto et al. (2013)
assessed the cerebral metabolome of GF mice and found 196
metabolites of which 23 were at least 1.6 fold higher in GF than in
ex-GF mice, while for 15 metabolites the reverse was true.
Metabolites involved in glycolytic pathways were signiﬁcantly
higher in GF than in ex-GF mice. Concentrations of DA were two-
fold higher in GF than in ex-GF mice. In the cerebrum of ex-GF
mice the concentration of tryptophan, the precursor of 5HT was
enhanced but they failed to ﬁnd differences in 5HT levels. Levels of
GABA were similar in the brains of GF and ex-GF mice but plasma
concentrations differed. This data is consistent with the view that
GABA produced by gut bacteria inﬂuences the brain via the vagus
nerve and not by directly acting within the brain.
A recent study (Clarke et al., 2013) demonstrated that the
consequences of growing up GF extends to a clear increase in the
hippocampus in both 5-HT and 5-hydroxyindoleacetic acid
(5-HIAA), its main metabolite, over the normal levels of these
neurochemicals. Despite the increased 5-HT concentration
observed, there was no altered expression of the Tph2 gene, the key
CNS isoform of the enzyme responsible for the synthesis of 5-HT
from tryptophan. No alteration in gene expression level was
found for either the SERT (serotonin transporter) gene or the rangeof serotonergic receptor genes evaluated (5-HT1A, 5-HT6 and
5-HT2C). The alterations observed are sex-speciﬁc, occurring only in
males, in contrast with the immunological and neuroendocrine
effects, which are evident in both sexes. Concentrations of trypto-
phan, the precursor of serotonin, are increased in the plasma of
male GF animals, suggesting a humoral route through which the
microbiota can inﬂuence CNS serotonergic neurotransmission.
Interestingly, colonization of the GF animals post-weaning is
insufﬁcient to reverse the CNS neurochemical consequences in
adulthood of an absent microbiota in early life despite the
peripheral availability of tryptophan being restored to baseline
values. In addition, reduced anxiety in GF animals is also normal-
ized following restoration of the intestinal microbiota. An earlier
study by Desbonnet et al. (2008) reported increases in tryptophan
levels in rats treated with the probiotic Biﬁdobacerium infantis
35624. This probiotic has been shown to have antidepressant action
in preclinical models of depression and may thus constitute a
psychobiotic with a mental health beneﬁt (Dinan et al., 2013).
Taken together, cumulating evidence points to key functions of
microbial genes in neuronal function, supplying the developing as
well as the mature brain with numerous neuroactive compounds,
which have impact on health and disease, and may lie at the heart
of behavioral disturbances when absent (Fig. 2).
6. BDNF and microbes
BDNF plays a pivotal role in supporting the survival of existing
neurons, and encourages the growth and differentiation of new
neurons and new synapse formations in the brain (Nicodemus
et al., 2014). It is especially active in areas which play a key role
in learning, memory, and higher cognitive activity, most notably
the hippocampus and cortex. It is now a decade since Sudo and
colleagues ﬁrst reported that GF mice have decreased levels of
BDNF protein in the hippocampus and cortex (Sudo et al., 2004).
A similar ﬁnding was reported by Clarke et al. (2013), but the
reduction was only seen in male and not in female mice. Neufeld
et al. (2011) reported a downregulation of BDNF mRNA in the
dentate region of the hippocampus in GF mice. In rats the probiotic
B. breve 6330 increased BDNF total variants, and decreased BDNF
splice variant IV in the hippocampus (O'sullivan et al., 2011). How
might the microbiota inﬂuence BDNF levels? Some data indicate
the involvement of short chain fatty acids. Butyrate, a histone
deacetylase inhibitor, has been shown to inﬂuence BDNF expres-
sion in the hippocampus (Martins-De-Souza, 2010). In a similar
vein Bercik and colleagues (Bercik et al., 2011) showed that
administration of oral antimicrobials to mice increased hippo-
campal expression of BDNF; however, these changes were inde-
pendent of inﬂammatory activity, changes in levels of
gastrointestinal neurotransmitters, and vagal or sympathetic
integrity. This group also demonstrated that the probiotic Biﬁdo-
bacterium longum normalized the changes in behavior and BDNF
mRNA induced by an intestinal parasite.
7. Microbes and cognition
Post-natal gut microbial colonization occurs in parallel with
cognitive development. There is increasing evidence to support the
view that the evolving cognitive activity is critically dependent on
themicrobiota and its metabolic activity. Gareau et al. (2011) used a
novel object recognition test and exploration of a T-maze to
examine dorsal hippocampal function in GF mice. The GF animals
displayed an absence of non-spatial and working memory accom-
panied by decreases in hippocampal brain derived neurotrophic
factor (BDNF) staining. The data indicate that compared with
colonized animals, GF mice display signiﬁcant cognitive deﬁcits.
Fig. 2. Some of the major deﬁcits in cognition, behavior and neurochemistry observed in germ-free mice. Abbreviation: Cort ¼ cortisosterone.
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the development of hippocampus-dependent memory. In another
study, Wall et al. (2012) demonstrated that ingestion of B. breve
NCIMB702258, but not B. breve 6330, signiﬁcantly impacted brain
fatty acid composition in mice, elevating arachidonic acid (AA) and
docosahexaenoic acid (DHA) concentrations, with potential clinical
implications as these fatty acids play important roles in cognitive
processes such as memory and learning.
Disorders of cognitive function such as Alzheimer's disease and
multi-infarct dementia have a high prevalence after the age of 65
years, with at least 40% of individuals at 85 years of age showing
some evidence of cognitive impairment (Hampel et al., 2011).
A causal association between gut microbes and cognitive decline in
the elderly has not yet been explored. Differences in the microbiota
of elderly subjects have been reported, with frail elderly and those
with cognitive dysfunction having the lowest diversity in gut mi-
crobial composition (Claesson et al., 2011, 2012). The ElderMet
consortium was established with the aim of characterizing the gut
microbiota of elderly (>65 years of age) Irish subjects. Recently, the
consortium demonstrated that Bacteroidetes and Firmicutes are
the dominant phyla in the distal gut of the elderly population,
contributing to 97% of the assigned sequences (Claesson et al., 2011,
2012). However, when the diversity of each individual was exam-
ined, huge variations at phylum level were evident. For example,
Firmicutes varied from 8% to 80%, whereas the phylum Bacter-
oidetes varied from 14% to 92%. These studies reported that 53% of
the core microbiota in elderly subjects comprised of Bacteroidetes,
compared with 8%e27% in younger adults.
It is therefore tempting to speculate that a changing microbiota
in the elderly also acts as a modulator of inﬂammatory processes inthe brain, which underlie many age-associated neurological dis-
eases, including dementia and especially Alzheimer's disease.
Diabetes mellitus is a well-established risk factor for dementia, and
a recently completed trial of a synbiotic (Lactobacillus acidophilus
plus prebiotic), which used a double-blind randomized design,
showed that consumption of the synbiotic food for 6 weeks had
signiﬁcant positive effects on serum insulin, C reactive protein and
uric acid (Asemi et al., 2014).
8. Microbes and social interaction
Mammals and especially humans are highly social beings.
Indeed, evolution may have favored the development of social
networks, and thereby increased capacity of our brain, to enhance
the transfer of beneﬁcial symbiotic microbes (Montiel-Castro et al.,
2013). Understanding the development of neuronal circuitries
underlying the social brain across the lifespan is one of the major
efforts in neuroscience today. That microbes may play a role in the
development of sociability has been proposed (Montiel-Castro
et al., 2013; Troyer, 1984; Lombardo, 2008) in the context of
evolutionary-based theories of the beneﬁts of mutualism in social
survival. In the following, we review the latest evidence for the
hypothesis that microbes shape human social behavior.
Autism spectrum disorders (ASD) are neurodevelopmental
disorders deﬁned by deﬁcits in social interaction and communi-
cation and the presence of limited, repetitive stereotyped interests
and behaviors (Autism, 2012). An increasing number of pre-clinical
studies are also supporting a link between ASDs and the
microbiota-gut-brain axis (Fig. 3). deTheije et al. (2013) used a
murine model of ASD to investigate the relation between the gut
Fig. 3. How animal models can be used to study the etiology and treatment of autism. (A) The three-chamber social interaction test is commonly used to investigate social behavior
such as sociability (Phase I) and social recognition memory (Phase II) in rodents. (B) Common gastrointestinal (GI) symptoms accompanying ASD diagnosis. *: the clinical picture is
not homogenous and most likely incomplete. Several symptoms may be observed only in a subset of cases. (C) Phenotype observed in current animal models of ASD. Abbreviations:
IBD, inﬂammatory bowel disease.
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technology, the composition of the gut microbiotawas investigated
in mice in utero exposed to valproic acid (VPA), an anticonvulsant
and epigenetic modulator. Furthermore, the levels of SCFAs and
lactic acid in feces were determined. The data demonstrate a
transgenerational impact of in utero VPA exposure on gut micro-
biota in the offspring. Such VPA exposure affected themain phyla of
Bacteroidetes and Firmicutes and the order of Desulfovibrionales.
In addition, alterations in Alistipes, Enterorhabdus, Mollicutes and
Erysipelotrichalis were especially associated with male VPA-
exposed offspring. The microbial differences of VPA in utero-
exposedmales deviated from those observed in females and was (i)
positively associated with increased levels of butyrate and (ii)
inversely associated with intestinal levels of serotonin and social
behavior scores.
The maternal immune activation mouse model is known to
display features of autism. Hsiao et al. (2013) showed that maternal
immune activation offspring display an altered serummetabolomic
proﬁle. They used oral treatment of such offspring with the human
commensal Bacteroides fragilis (B. fragilis). Treatment corrected gut
permeability, altered microbial composition, and ameliorated de-
fects in communicative, stereotypic, anxiety-like and sensorimotor
behaviors. Treatingnaivemicewith ametabolite that is increased by
maternal immune activation andnormalized byB. fragilis resulted in
behavioral abnormalities, supporting the view that gut bacterialeffects on the host metabolome impact behavior. Taken together,
these ﬁndings suggest a gutemicrobiomeebrain connection in a
mouse model of autism and identify a potential probiotic therapy.
Desbonnet et al. (2014) examined social behavior in GF mice
using the three chamber sociability test. In the ﬁrst study a GF
mouse was placed in the middle chamber with a second mouse in
the ﬁrst chamber and an object in the third. A conventionally
colonized mouse tends to spend more time with a second mouse
than with an object, while the GF mouse spends far less time with
another mouse and a greater amount of time with the object. In a
second experiment, a GF mouse or a conventionally colonized
mouse is placed in themiddle chamberwith a familiarmouse in the
ﬁrst chamber and an unfamiliar mouse in the third chamber. The
conventionally colonized mouse spends more time with the unfa-
miliar mouse while the GF mouse shows no preference for either
the familiar or unfamiliar mouse. The overall pattern of behavior in
GF mice is therefore highly parallel to symptoms observed in
autistic patients. Yet, there is a capacity for reversal if the animal is
colonized at an early stage.
Altered faecal concentrations of SCFAs have also been reported
in ASD (Allen, 1997). Of note is the fact that administration of
propionic acid, an SCFA, to animals via the intracerebroventricular
route results in some autistic-like behaviors (Couillin et al., 1994),
albeit it at high doses that might not reﬂect the clinically observed
alterations.
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ported (Cao et al., 2013), but as Gonzalez et al. (Collins et al., 2012)
point out, studies of the gut microbiota in children with autism
have been very limited, usually with small sample sizes, shallow
sequencing of bacterial 16S rRNA gene amplicons, and without
concomitant analyses of (i) the microbiome gene content (by
shotgun sequencing of total faecal community DNA), (ii) micro-
biome gene expression, or (iii) microbial metabolism. Thus, the
studies undertaken so far do not yet produce a homogenous or
complete picture and clearly more systematic studies are needed.
However, several studies repeatedly report a high co-morbidity of
ASDs with gastrointestinal symptoms.
In conclusion, these data point to a critical role of microbial cues
that affect brain development and especially impacts those
neuronal circuitries that underlie social behavior in mammals.
However, while there have undoubtedly been advances in animal
models of ASD, some results from the various models are difﬁcult to
reconcile (Tania et al., 2014).
9. Microbiota and stress
The Yerkes-Dodson law states that stress can have a positive
impact to a certain pivot point, beyond which the inﬂuence is
deleterious (Bregman and Mcallister, 1983). The position of the
pivot point is determined by multiple factors including the gut
microbiota. Seminal studies by Sudo and colleagues (Sudo et al.,
2004) provide insight into the role of the intestinal microbiota in
the development of the core stress axis, the HPA. In GF mice, a mild
restraint stress induces an exaggerated release of corticosterone
and adrenocorticotropic hormone (ACTH) compared to the speciﬁc
pathogen free (SPF) controls. The aberrant stress response in GF
mice is reversed by monoassociation with B. infantis in a time
dependent manner. This study clearly demonstrated that the
microbial presence in the gut is critical to the development of an
appropriate stress response later in life and also that there is a
narrow window in early life where colonization must occur to
ensure normal development of the HPA axis.
Early maternal separation produces long-term alterations in
behavior, the HPA and the gut microbiota. Using such a model in
rats, Desbonnet et al. (2008) found that treatment with the pro-
biotic B. infantis normalized stress-related behavior but did not
reduce corticosterone. Using a similar model Gareau et al. (2011)
found that feeding a Lactobacillus spp. reduced corticosterone
levels. Surprisingly, data from studies in rodents suggest that an
anxious or a non-anxious phenotype can be induced with a
microbiota transplant from an animal with a similar phenotype
(Collins et al., 2013).
In a ground breaking functional magnetic resonance imaging
(fMRI) brain scan study Tillisch et al. (2013) showed that ingestion
of a probiotic cocktail altered information processing of emotional
material. In another human intervention study, healthy volunteers
were given Lactobacillus helveticus R0052 and Biﬁdobacterium lon-
gum R0175 in combination or placebo in a double-blind, random-
ized parallel group study for 30 days. Twenty-four hour urinary free
cortisol (UFC) output was reduced with probiotic treatment
(Messaoudi et al., 2011). These studies provide important evidence
that psychobiotics can alter mental processes and reduce stress
responses. Resilience to environmental stress seems to be heavily
inﬂuenced by microbial composition. This effect is most likely
dependent on alterations of the HPA axis, and can be positively
inﬂuenced by certain probiotic bacterial species. In support of this
suggestion is the recent ﬁnding that prebiotic treatment, which is
known to increase probiotic levels in the gut, alters the cortisol
awaking response and emotional reaction in healthy subjects
(Schmidt et al., 2014). Since stress beyond the pivot point isbecoming an increasing burden for our societies, we should now
aim to translate these ﬁndings into safe supplements and dietary
recommendations.
10. Concluding remarks
During the course of evolution, multicellular life emerged from
unicellular life forms. The latter remain the dominant life form on
the planet and often exist in a symbiotic or parasitic relationship
with multicellular life. The nature of such relationships can have a
major inﬂuence on the life cycle of plants and animals. Here, we
propose that the development of a complex gut microbiota in
mammals has played an important role in enabling brain devel-
opment, especially in terms of cognitive function and fundamental
behavior patterns, such as facilitating social interaction and effec-
tively dealing with environmental stressors. Thus, future studies of
how gut microbes contribute to the function of their host on all
levels will play an important role in advancing understanding of
disorders of cognitive functioning as well as disorders of social
interaction such as autism and a variety of stress-related condi-
tions. Within a relatively short period of time, results of clinical
trials of probiotics (psychobiotics) and prebiotics in the treatment
of common psychiatric disorders will be available.
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